The prognostic significance of BMP-6 signaling in prostate cancer (Q44237762)

1 December 2017

title

The prognostic significance of BMP-6 signaling in prostate cancer (English)

1 reference

1 December 2017

Hiu-Fung Yuen

1

1 reference

1 December 2017

Yuen-Piu Chan

2

1 reference

1 December 2017

Wai-Lok Cheung

3

1 reference

1 December 2017

Yong-Chuan Wong

4

1 reference

1 December 2017

Xianghong Wang

5

1 reference

1 December 2017

Kwok-Wah Chan

6

1 reference

1 December 2017

publication date

17 October 2008

1 reference

1 December 2017

1 reference

1 December 2017

volume

21

1 reference

1 December 2017

issue

12

1 reference

1 December 2017

page(s)

1436-1443

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.94

1 December 2017

exact match

0 references

cites work

Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Do patients with localized prostate cancer treatment really want more aggressive treatment?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic protein-6 expression in normal and malignant prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

BMP antagonists: their roles in development and involvement in pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.94

7 January 2021

10.1038/MODPATHOL.2008.94

Identifiers

DOI

1 reference

1 December 2017

1 reference